Cargando…

LOGIC-Insulin Algorithm–Guided Versus Nurse-Directed Blood Glucose Control During Critical Illness: The LOGIC-1 single-center, randomized, controlled clinical trial

OBJECTIVE: Tight blood glucose control (TGC) in critically ill patients is difficult and labor intensive, resulting in poor efficacy of glycemic control and increased hypoglycemia rate. The LOGIC-Insulin computerized algorithm has been developed to assist nurses in titrating insulin to maintain bloo...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Herpe, Tom, Mesotten, Dieter, Wouters, Pieter J., Herbots, Jeroen, Voets, Evy, Buyens, Jo, De Moor, Bart, Van den Berghe, Greet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554274/
https://www.ncbi.nlm.nih.gov/pubmed/22961576
http://dx.doi.org/10.2337/dc12-0584
_version_ 1782256864890716160
author Van Herpe, Tom
Mesotten, Dieter
Wouters, Pieter J.
Herbots, Jeroen
Voets, Evy
Buyens, Jo
De Moor, Bart
Van den Berghe, Greet
author_facet Van Herpe, Tom
Mesotten, Dieter
Wouters, Pieter J.
Herbots, Jeroen
Voets, Evy
Buyens, Jo
De Moor, Bart
Van den Berghe, Greet
author_sort Van Herpe, Tom
collection PubMed
description OBJECTIVE: Tight blood glucose control (TGC) in critically ill patients is difficult and labor intensive, resulting in poor efficacy of glycemic control and increased hypoglycemia rate. The LOGIC-Insulin computerized algorithm has been developed to assist nurses in titrating insulin to maintain blood glucose levels at 80–110 mg/dL (normoglycemia) and to avoid severe hypoglycemia (<40 mg/dL). The objective was to validate clinically LOGIC-Insulin relative to TGC by experienced nurses. RESEARCH DESIGN AND METHODS: The investigator-initiated LOGIC-1 study was a prospective, parallel-group, randomized, controlled clinical trial in a single tertiary referral center. A heterogeneous mix of 300 critically ill patients were randomized, by concealed computer allocation, to either nurse-directed glycemic control (Nurse-C) or algorithm-guided glycemic control (LOGIC-C). Glycemic penalty index (GPI), a measure that penalizes both hypoglycemic and hyperglycemic deviations from normoglycemia, was the efficacy outcome measure, and incidence of severe hypoglycemia (<40 mg/dL) was the safety outcome measure. RESULTS: Baseline characteristics of 151 Nurse-C patients and 149 LOGIC-C patients and study times did not differ. The GPI decreased from 12.4 (interquartile range 8.2–18.5) in Nurse-C to 9.8 (6.0–14.5) in LOGIC-C (P < 0.0001). The proportion of study time in target range was 68.6 ± 16.7% for LOGIC-C patients versus 60.1 ± 18.8% for Nurse-C patients (P = 0.00016). The proportion of severe hypoglycemic events was decreased in the LOGIC-C group (Nurse-C 0.13%, LOGIC-C 0%; P = 0.015) but not when considered as a proportion of patients (Nurse-C 3.3%, LOGIC-C 0%; P = 0.060). Sampling interval was 2.2 ± 0.4 h in the LOGIC-C group versus 2.5 ± 0.5 h in the Nurse-C group (P < 0.0001). CONCLUSIONS: Compared with expert nurses, LOGIC-Insulin improved efficacy of TGC without increasing rate of hypoglycemia.
format Online
Article
Text
id pubmed-3554274
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-35542742014-02-01 LOGIC-Insulin Algorithm–Guided Versus Nurse-Directed Blood Glucose Control During Critical Illness: The LOGIC-1 single-center, randomized, controlled clinical trial Van Herpe, Tom Mesotten, Dieter Wouters, Pieter J. Herbots, Jeroen Voets, Evy Buyens, Jo De Moor, Bart Van den Berghe, Greet Diabetes Care Original Research OBJECTIVE: Tight blood glucose control (TGC) in critically ill patients is difficult and labor intensive, resulting in poor efficacy of glycemic control and increased hypoglycemia rate. The LOGIC-Insulin computerized algorithm has been developed to assist nurses in titrating insulin to maintain blood glucose levels at 80–110 mg/dL (normoglycemia) and to avoid severe hypoglycemia (<40 mg/dL). The objective was to validate clinically LOGIC-Insulin relative to TGC by experienced nurses. RESEARCH DESIGN AND METHODS: The investigator-initiated LOGIC-1 study was a prospective, parallel-group, randomized, controlled clinical trial in a single tertiary referral center. A heterogeneous mix of 300 critically ill patients were randomized, by concealed computer allocation, to either nurse-directed glycemic control (Nurse-C) or algorithm-guided glycemic control (LOGIC-C). Glycemic penalty index (GPI), a measure that penalizes both hypoglycemic and hyperglycemic deviations from normoglycemia, was the efficacy outcome measure, and incidence of severe hypoglycemia (<40 mg/dL) was the safety outcome measure. RESULTS: Baseline characteristics of 151 Nurse-C patients and 149 LOGIC-C patients and study times did not differ. The GPI decreased from 12.4 (interquartile range 8.2–18.5) in Nurse-C to 9.8 (6.0–14.5) in LOGIC-C (P < 0.0001). The proportion of study time in target range was 68.6 ± 16.7% for LOGIC-C patients versus 60.1 ± 18.8% for Nurse-C patients (P = 0.00016). The proportion of severe hypoglycemic events was decreased in the LOGIC-C group (Nurse-C 0.13%, LOGIC-C 0%; P = 0.015) but not when considered as a proportion of patients (Nurse-C 3.3%, LOGIC-C 0%; P = 0.060). Sampling interval was 2.2 ± 0.4 h in the LOGIC-C group versus 2.5 ± 0.5 h in the Nurse-C group (P < 0.0001). CONCLUSIONS: Compared with expert nurses, LOGIC-Insulin improved efficacy of TGC without increasing rate of hypoglycemia. American Diabetes Association 2013-02 2013-01-17 /pmc/articles/PMC3554274/ /pubmed/22961576 http://dx.doi.org/10.2337/dc12-0584 Text en © 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Original Research
Van Herpe, Tom
Mesotten, Dieter
Wouters, Pieter J.
Herbots, Jeroen
Voets, Evy
Buyens, Jo
De Moor, Bart
Van den Berghe, Greet
LOGIC-Insulin Algorithm–Guided Versus Nurse-Directed Blood Glucose Control During Critical Illness: The LOGIC-1 single-center, randomized, controlled clinical trial
title LOGIC-Insulin Algorithm–Guided Versus Nurse-Directed Blood Glucose Control During Critical Illness: The LOGIC-1 single-center, randomized, controlled clinical trial
title_full LOGIC-Insulin Algorithm–Guided Versus Nurse-Directed Blood Glucose Control During Critical Illness: The LOGIC-1 single-center, randomized, controlled clinical trial
title_fullStr LOGIC-Insulin Algorithm–Guided Versus Nurse-Directed Blood Glucose Control During Critical Illness: The LOGIC-1 single-center, randomized, controlled clinical trial
title_full_unstemmed LOGIC-Insulin Algorithm–Guided Versus Nurse-Directed Blood Glucose Control During Critical Illness: The LOGIC-1 single-center, randomized, controlled clinical trial
title_short LOGIC-Insulin Algorithm–Guided Versus Nurse-Directed Blood Glucose Control During Critical Illness: The LOGIC-1 single-center, randomized, controlled clinical trial
title_sort logic-insulin algorithm–guided versus nurse-directed blood glucose control during critical illness: the logic-1 single-center, randomized, controlled clinical trial
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554274/
https://www.ncbi.nlm.nih.gov/pubmed/22961576
http://dx.doi.org/10.2337/dc12-0584
work_keys_str_mv AT vanherpetom logicinsulinalgorithmguidedversusnursedirectedbloodglucosecontrolduringcriticalillnessthelogic1singlecenterrandomizedcontrolledclinicaltrial
AT mesottendieter logicinsulinalgorithmguidedversusnursedirectedbloodglucosecontrolduringcriticalillnessthelogic1singlecenterrandomizedcontrolledclinicaltrial
AT wouterspieterj logicinsulinalgorithmguidedversusnursedirectedbloodglucosecontrolduringcriticalillnessthelogic1singlecenterrandomizedcontrolledclinicaltrial
AT herbotsjeroen logicinsulinalgorithmguidedversusnursedirectedbloodglucosecontrolduringcriticalillnessthelogic1singlecenterrandomizedcontrolledclinicaltrial
AT voetsevy logicinsulinalgorithmguidedversusnursedirectedbloodglucosecontrolduringcriticalillnessthelogic1singlecenterrandomizedcontrolledclinicaltrial
AT buyensjo logicinsulinalgorithmguidedversusnursedirectedbloodglucosecontrolduringcriticalillnessthelogic1singlecenterrandomizedcontrolledclinicaltrial
AT demoorbart logicinsulinalgorithmguidedversusnursedirectedbloodglucosecontrolduringcriticalillnessthelogic1singlecenterrandomizedcontrolledclinicaltrial
AT vandenberghegreet logicinsulinalgorithmguidedversusnursedirectedbloodglucosecontrolduringcriticalillnessthelogic1singlecenterrandomizedcontrolledclinicaltrial